Related Experiment Videos
Allosteric modulation of the cannabinoid CB1 receptor
Martin R Price1, Gemma L Baillie, Adèle Thomas
1School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland.
Molecular Pharmacology
|August 23, 2005
Summary
Novel Org compounds act as allosteric modulators at the cannabinoid CB1 receptor, demonstrating a unique binding mechanism. These compounds exhibit insurmountable antagonism, revealing a previously unrecognized allosteric site on the CB1 receptor.
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- The cannabinoid CB1 receptor is a key target for various physiological processes.
- Understanding the allosteric modulation of CB1 receptor is crucial for developing novel therapeutics.
- Previous research has primarily focused on orthosteric ligands for CB1 receptor modulation.
Purpose of the Study:
- To investigate the pharmacological properties of three novel compounds (Org 27569, Org 27759, Org 29647) at the cannabinoid CB1 receptor.
- To determine if these compounds exhibit allosteric binding and functional modulation.
- To characterize the interaction of these compounds with the CB1 receptor using binding and functional assays.
Main Methods:
- Equilibrium binding assays using radioligands ([3H]CP 55,940 and [3H]SR 141716A) to assess binding affinity and cooperativity.
- Allosteric ternary complex model analysis to interpret binding data.
- Radioligand dissociation kinetic studies to confirm allosteric modulation.
- Functional assays including reporter gene assays, guanosine 5'-O-(3-[35S]thio)triphosphate binding assays, and mouse vas deferens assays to evaluate receptor activity.
Main Results:
- Org compounds demonstrated positively cooperative allosteric effects with the CB1 receptor agonist [3H]CP 55,940.
- A limited negative binding cooperativity was observed with the CB1 receptor inverse agonist [3H]SR 141716A.
- Kinetic studies confirmed the allosteric nature of Org compounds, showing decreased radioligand dissociation.
- In functional assays, Org compounds acted as insurmountable antagonists, reducing the Emax of CB1 receptor agonists.
Conclusions:
- The Org compounds bind allosterically to the CB1 receptor, inducing conformational changes that affect agonist binding.
- This study provides the first evidence of a synthetic small molecule ligand recognizing an allosteric binding site on the cannabinoid CB1 receptor.
- These findings open new avenues for the development of CB1 receptor-targeted drugs with unique mechanisms of action.